"Designing Growth Strategies is in our DNA"

China Point-of-Care Sepsis Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Kits), By Technology (Molecular Diagnostics and Immunoassays), By Pathogen (Bacterial Sepsis and Fungal Sepsis), By End User (Hospitals & Clinics and Standalone Laboratories), and Country Forecast, 2024-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI110940

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Sepsis Incidence, China, 2023
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
    3. Overview: Point of Care Sepsis Diagnostics, By Emerging Companies
    4. Technological Advancements in Point-of-Care Sepsis Diagnostics
    5. Regulatory & Reimbursement Scenario, By Key Countries
    6. Overview: Novel Sepsis Biomarker
    7. Key Players, Immunoassay Point-of-Care Sepsis
    8. Impact of COVID-19 Pandemic on China Point-of-Care Sepsis Diagnostics Market
  5. China Point-of-Care Sepsis Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Technology
      1. Molecular Diagnostics
      2. Immunoassays
    3. Market Analysis, Insights and Forecast – By Pathogen
      1. Bacterial Sepsis
      2. Fungal Sepsis
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Clinics
      2. Standalone Laboratories
  6. Competitive Analysis
    1. Market Share Analysis (2023)
    2. Key Companies for Countries in the Scope
    3. Company Profiles
      1. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Radiometer Medical ApS (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. bioMérieux, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. DiaSorin S.p.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. T2 Biosystems, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Wondfu
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Boditech Med Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Lepu Medical Technology (Beijing)Co.,Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: China Point-of-Care Sepsis Diagnostics Market Value Share (%), by Product Type, 2023 & 2032

Figure 2: China Point-of-Care Sepsis Diagnostics Market Value Share (%), by Technology, 2023 & 2032

Figure 3: China Point-of-Care Sepsis Diagnostics Market Value Share (%), by Pathogen, 2023 & 2032

Figure 4: China Point-of-Care Sepsis Diagnostics Market Value Share (%), by End User, 2023 & 2033

Figure 5: China Point-of-Care Sepsis Diagnostics Market Share (%), 2023

Table 1: China Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Product Type, 2019–2032

Table 2: China Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Technology, 2019–2032

Table 3: China Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by Pathogen, 2019–2032

Table 4: China Point-of-Care Sepsis Diagnostics Market Revenue (USD million) Forecast, by End User, 2019-2032

China Point-of-Care Sepsis Diagnostics Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 132
Consulting Services
    How will you benefit from our consulting services ?